PARP inhibitor BMN-673 8R,9S, Purity ≥98%

Cat. No.: X23-10-ZQ235

PARP inhibitor BMN-673 8R,9S, Purity ≥98%

Synonym: 1207456-00-5; BMN-673 8R,9S,(8R,9S)-Talazoparib; (8R,9S)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one; PARP inhibitor

  • MDL: MFCD25372032
  • CAS Number: 1207456-00-5
  • Compound CID: 135742498
Product Size
5 mg; 10 mg; 25 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
BMN-673 8R,9S binds to the PARP enzyme's active site, preventing it from repairing single-strand DNA breaks.
Molecular Weight
380.35
Molecular Formula
C19H14F2N6O
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
BMN-673 can be used to explore its effects as a PARP inhibitor in cancer treatment.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.